????? ?? ?? ? ??? ????????????? ????????????????? ???????????????????gene in patients relapsing following remedy With all the BCL2 antagonist venetoclax. sixty six Resistance to those agents has become connected to these mutations in around 70% of situations, Whilst they tend to be subclonal and their distinct job creating resistance should be conf